Lack of neurotoxic effect of diethylpropion in crack-cocaine abusers

Clinical Neuropharmacology

Volumn 19, Issue 1, 1996, Pages 52-58

  Ollo, Christine ^a   Alim, Tanya N ^a,b   Rosse, Richard B ^a   Lindquist, Teresa ^a   Green, Thomas ^a   Gillis, Tama ^a   Ricci, Judy ^a   Khan, Mushtari ^a   Deutsch, Stephen I ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Cognition; Crack cocaine abuse; Diethylpropion; Neuropsychology; Stimulants

Indexed keywords

AMANTADINE; AMFEPRAMONE; BROMOCRIPTINE; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; METHYLPHENIDATE;

ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROTOXICITY; PRIORITY JOURNAL; TASK PERFORMANCE;

EID: 0030028363     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619010-00003     Document Type: Article

References (47)

1. Chang JY, Sawyer SF, Lee RS, Woodward DJ. Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J Neurosci 1994;14:1224-44.
2. Gawin FH, Ellinwood EH. Cocaine and other stimulants. N Engl J Med 1988;318:1173-82.
3. Gawin FH. Cocaine addiction: psychology and neurophysiology. Science 1991;251:1580-6.
4. Caine SB, Koob GF. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 1993;260:1814-16.
5. Dackis CA, Gold MS, Sweeney DR, Byron JP, Climko R. Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987;20:261-4.
6. Tennant FS Jr, Sagherian AA. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 1987;147:109-12.
7. Giannini AJ, Foils DJ, Feather JN, Sullivan BS. Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res 1989;29:11-16.
8. Khantzian EJ, Gawin F, Kleber HD, Riordan CE. Methylphenidate treatment of cocaine dependence - a preliminary report. J Subst Abuse Treat 1984;1:107-12.
9. Weiss RD, Pope HG, Mirin SM. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. Drug Alcohol Depend 1985;15:169-72.
10. Gawin FH, Morgan C, Kosten TR, Kleber HD. Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology 1989;97:402-3.
11. Gawin FH, Riordan C, Kleber H. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 1985;11:193-7.
12. Kranzler HR, Bauer LO. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br J Addiction 1992;87:1537-48.
13. Kleven MS, Seiden LS. Methamphetamine-induced neurotoxicity: structure activity relationships. Ann NY Acad Sci 1992;654:292-301.
14. King GR, Ellinwood H Jr. Amphetamines and other stimulants. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance abuse: a comprehensive textbook, 2nd ed. Baltimore: Williams and Wilkins, 1992:247-70.
15. Ricaurte GA, McCann UD. Neurotoxic amphetamine analogues: Effects in monkeys and implications for humans. Ann NY Acad Sci 1992;648:371-82.
16. Ellison G. Continuous amphetamine and cocaine have similar neurotoxic effects in lateral habenular nucleus and fasciculus retroflexus. Brain Res 1992;598:353-6.
17. Ellison G, Switzer RC. Dissimilar patterns of degeneration in brain following four different addictive stimulants. Neuroreport 1993;5:17-20.
18. Seiden LS, Ricaurte GA. Neurotoxicity of metamphetamine and related drugs. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:359-66.
19. Ellison G, Eison MS, Huberman HS, Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 1978;201-76,78.
20. Ricaurte GA, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 1980;193:153-63.
21. Kleven MS, Seiden LS. Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in the striatum. Ann NY Acad Sci 1992;654:464-6.
22. Schmidt C. L-Dopa potentiates the neurotoxicity of some amphetamine analogues. Ann NY Acad Sci 1992;648:343-4.
23. Pentel PR, Thompson TN. Potential adverse interactions of drugs with cocaine. NIDA Research Monograph 123, 1992:156-71.
24. Alim TA, Rosse RB, Vocci FJ Jr, Deutsch SI. Open-label, dose run-up study of diethylpropion in initial cocaine abstinence. Clin Neuropharmacol 1994;17:175-87.
25. Jasinski DR, Nutt JG, Griffith JD. Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration. Clin Pharmacol Ther 1974;16:645-52.
26. Spitzer RL, Williams JBW, Gibbin M, et al. Structured Clinical Interview DSM-III-R. Patient Edition (SCID-P, Version 1.0). Washington DC: American Psychiatric Press. 1990.
27. Fureman B, Parikh G, Bragg A, McLellan AT. Addiction Severity Index. 5th ed. Philadelphia: University of Pennsylvania/Veterans Administration Center for Studies on Addiction, 1990.
28. Satel SL, Southwick SM, Gawin FH. Clinical features of cocaine-induced paranoia. Am J Psychiatry 1991;148:495-8.
29. Wechsler D. Wechsler Adult Intelligence Scale Revised (manual). Cleveland: The Psychological Corporation, 1981.
30. Jastak S, Wilkinson OS. The Wide Range Achievement Test-Revised. Administration Manual. Wilmington: Jastak, 1984.
31. Delis DC, Kramer JH, Kaplan E, Ober B. The California Verbal Learning Test (manual). New York: The Psychological Corporation. 1987.
32. Delis DC, McKee R, Massman PJ, Kramer JH, Kaplan E, Gettman D. Alternate form of the California Verbal Learning Test: development and reliability. Clin Neuropsychologist 1991;5:154-62.
33. Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press, 1991.
34. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1983.
35. Bornstein RA. Normative data on selected neuropsychological measures from a nonclinical sample. J Clin Psychol 1985;41:651-9.
36. Golden CJ. Stroop Color and Word Test: a manual for clinical and experimental uses. Chicago: Stocking, 1978.
37. Koller WC. When does Parkinson's disease begin? Neurology 1992;42(suppl 4):27-31.
38. Yoshikawa T, Minamiyama Y, Naito Y, Kondo M. Antioxidant properties of bromocriptine, a dopamine agonist. J Neurochem 1994;62:1034-8.
39. Okazawa H, Murata M, Watanabe M, Kamei M, Kanazawa I. Dopaminergic stimulation upregulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Lett 1992;313:138-42.
40. Feeney DM, Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res 1985;342:352-6.
41. Sutton RL, Hovda D, Feeney D. Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. Behav Neurosci 1989;103:837-41.
42. Hitri A, Wyatt RJ. Regional differences in rat brain dopamine transporter binding: function of time after chronic cocaine. Clin Neuropharmacol 1993;16:525-39.
43. Neiswander JL, Lucki I, McGonigle P. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Synapse 1994;16:1-10.
44. Eisch AJ, Gaffney M, Weihmuller FB, O'Dell SJ, Marshall JF. Striatal subrogions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 1992;598:321-6.
45. Ryan LJ, Linder JC, Marione ME, Groves PM. Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res 1990;518:67-77.
46. Alim TA, Rosse RB, Vocci FJ Jr, Lindquist T, Deutsch SI. Diethylpropion pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence: a test of the cocaine-agonist hypothesis. Clin Neuropharmacol 1995;18:183-95.
47. Hitzig P. Combined dopamine and serotonin agonists: a synergistic approach to alcoholism and other addictive behaviors. Md Med J 1993;42:153-6.